Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Herman Miller, Inc. (MLHR) Going to Burn These Hedge Funds?

Page 1 of 2

What’s a smart Herman Miller, Inc. (NASDAQ:MLHR) investor to do?

To the average investor, there are dozens of methods shareholders can use to monitor stocks. A pair of the best are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best money managers can outclass the broader indices by a very impressive amount (see just how much).

Equally as crucial, bullish insider trading sentiment is a second way to analyze the financial markets. There are plenty of reasons for an executive to get rid of shares of his or her company, but only one, very simple reason why they would initiate a purchase. Many empirical studies have demonstrated the market-beating potential of this strategy if shareholders know where to look (learn more here).

Thus, let’s analyze the newest info surrounding Herman Miller, Inc. (NASDAQ:MLHR).

What does the smart money think about Herman Miller, Inc. (NASDAQ:MLHR)?

At the end of the second quarter, a total of 11 of the hedge funds we track were bullish in this stock, a change of 0% from the first quarter. With the smart money’s sentiment swirling, there exists a select group of notable hedge fund managers who were upping their stakes significantly.

Herman Miller, Inc. (NASDAQ:MLHR)Out of the hedge funds we follow, Natixis Global Asset Management’s Harris Associates had the largest position in Herman Miller, Inc. (NASDAQ:MLHR), worth close to $54.4 million, accounting for 0.1% of its total 13F portfolio. Sitting at the No. 2 spot is Pzena Investment Management, managed by Richard S. Pzena, which held a $23.6 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Other hedgies that hold long positions include Matthew Lindenbaum’s Basswood Capital, Tom Russo’s Gardner Russo & Gardner and Joel Greenblatt’s Gotham Asset Management.

Because Herman Miller, Inc. (NASDAQ:MLHR) has faced dropping sentiment from the top-tier hedge fund industry, it’s easy to see that there were a few money managers who were dropping their full holdings last quarter. It’s worth mentioning that D. E. Shaw’s D E Shaw cut the biggest investment of the “upper crust” of funds we monitor, valued at close to $1.5 million in stock. Matthew Tewksbury’s fund, Stevens Capital Management, also said goodbye to its stock, about $1 million worth. These transactions are intriguing to say the least, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

How have insiders been trading Herman Miller, Inc. (NASDAQ:MLHR)?

Legal insider trading, particularly when it’s bullish, is best served when the company in focus has seen transactions within the past 180 days. Over the last six-month time period, Herman Miller, Inc. (NASDAQ:MLHR) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Herman Miller, Inc. (NASDAQ:MLHR). These stocks are Knoll Inc (NYSE:KNL), Pitney Bowes Inc. (NYSE:PBI), VeriFone Systems Inc (NYSE:PAY), Steelcase Inc. (NYSE:SCS), and HNI Corp (NYSE:HNI). This group of stocks are the members of the business equipment industry and their market caps are similar to MLHR’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!